Cargando…
A deterministic linear infection model to inform Risk-Cost-Benefit Analysis of activities during the SARS-CoV-2 pandemic
Risk-cost-benefit analysis requires the enumeration of decision alternatives, their associated outcomes, and the quantification of uncertainty. Public and private decision-making surrounding the COVID-19 pandemic must contend with uncertainty about the probability of infection during activities invo...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457623/ https://www.ncbi.nlm.nih.gov/pubmed/32869042 http://dx.doi.org/10.1101/2020.08.23.20180349 |
_version_ | 1783576031114821632 |
---|---|
author | McCarthy, John E. Dumas, Bob A. McCarthy, Myles T. Dewitt, Barry D. |
author_facet | McCarthy, John E. Dumas, Bob A. McCarthy, Myles T. Dewitt, Barry D. |
author_sort | McCarthy, John E. |
collection | PubMed |
description | Risk-cost-benefit analysis requires the enumeration of decision alternatives, their associated outcomes, and the quantification of uncertainty. Public and private decision-making surrounding the COVID-19 pandemic must contend with uncertainty about the probability of infection during activities involving groups of people, in order to decide whether that activity is worth undertaking. We propose a deterministic linear model of SARS-CoV-2 infection probability that can produce estimates of relative risk for diverse activities, so long as those activities meet a list of assumptions, including that they do not last longer than one day. We show how the model can be used to inform decisions facing governments and industry, such as opening stadiums or flying on airplanes. We prove that the model is a good approximation of a more refined model in which we assume infections come from a series of independent risks. The linearity assumption makes interpreting and using the model straightforward, and we argue that it does so without significantly diminishing the reliability of the model. |
format | Online Article Text |
id | pubmed-7457623 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Cold Spring Harbor Laboratory |
record_format | MEDLINE/PubMed |
spelling | pubmed-74576232020-09-01 A deterministic linear infection model to inform Risk-Cost-Benefit Analysis of activities during the SARS-CoV-2 pandemic McCarthy, John E. Dumas, Bob A. McCarthy, Myles T. Dewitt, Barry D. medRxiv Article Risk-cost-benefit analysis requires the enumeration of decision alternatives, their associated outcomes, and the quantification of uncertainty. Public and private decision-making surrounding the COVID-19 pandemic must contend with uncertainty about the probability of infection during activities involving groups of people, in order to decide whether that activity is worth undertaking. We propose a deterministic linear model of SARS-CoV-2 infection probability that can produce estimates of relative risk for diverse activities, so long as those activities meet a list of assumptions, including that they do not last longer than one day. We show how the model can be used to inform decisions facing governments and industry, such as opening stadiums or flying on airplanes. We prove that the model is a good approximation of a more refined model in which we assume infections come from a series of independent risks. The linearity assumption makes interpreting and using the model straightforward, and we argue that it does so without significantly diminishing the reliability of the model. Cold Spring Harbor Laboratory 2020-08-25 /pmc/articles/PMC7457623/ /pubmed/32869042 http://dx.doi.org/10.1101/2020.08.23.20180349 Text en http://creativecommons.org/licenses/by-nc/4.0/It is made available under a CC-BY-NC 4.0 International license (http://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Article McCarthy, John E. Dumas, Bob A. McCarthy, Myles T. Dewitt, Barry D. A deterministic linear infection model to inform Risk-Cost-Benefit Analysis of activities during the SARS-CoV-2 pandemic |
title | A deterministic linear infection model to inform Risk-Cost-Benefit Analysis of activities during the SARS-CoV-2 pandemic |
title_full | A deterministic linear infection model to inform Risk-Cost-Benefit Analysis of activities during the SARS-CoV-2 pandemic |
title_fullStr | A deterministic linear infection model to inform Risk-Cost-Benefit Analysis of activities during the SARS-CoV-2 pandemic |
title_full_unstemmed | A deterministic linear infection model to inform Risk-Cost-Benefit Analysis of activities during the SARS-CoV-2 pandemic |
title_short | A deterministic linear infection model to inform Risk-Cost-Benefit Analysis of activities during the SARS-CoV-2 pandemic |
title_sort | deterministic linear infection model to inform risk-cost-benefit analysis of activities during the sars-cov-2 pandemic |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457623/ https://www.ncbi.nlm.nih.gov/pubmed/32869042 http://dx.doi.org/10.1101/2020.08.23.20180349 |
work_keys_str_mv | AT mccarthyjohne adeterministiclinearinfectionmodeltoinformriskcostbenefitanalysisofactivitiesduringthesarscov2pandemic AT dumasboba adeterministiclinearinfectionmodeltoinformriskcostbenefitanalysisofactivitiesduringthesarscov2pandemic AT mccarthymylest adeterministiclinearinfectionmodeltoinformriskcostbenefitanalysisofactivitiesduringthesarscov2pandemic AT dewittbarryd adeterministiclinearinfectionmodeltoinformriskcostbenefitanalysisofactivitiesduringthesarscov2pandemic AT mccarthyjohne deterministiclinearinfectionmodeltoinformriskcostbenefitanalysisofactivitiesduringthesarscov2pandemic AT dumasboba deterministiclinearinfectionmodeltoinformriskcostbenefitanalysisofactivitiesduringthesarscov2pandemic AT mccarthymylest deterministiclinearinfectionmodeltoinformriskcostbenefitanalysisofactivitiesduringthesarscov2pandemic AT dewittbarryd deterministiclinearinfectionmodeltoinformriskcostbenefitanalysisofactivitiesduringthesarscov2pandemic |